Okomera is a biotech start-up that accelerates access to improved, precision-based cancer therapies.
Okomera has raised $1.6M in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Okomera's investors include Bpifrance, SkyDeck Berkeley, Berkeley SkyDeck Fund, Polytechnique Ventures, AGORANOV.
Okomera is headquartered in Paris, France.
Okomera is a biotech start-up that accelerates access to improved, precision-based cancer therapies.
Okomera is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Okomera — Funding & Investors." VCBacked, October 21, 2024, https://www.vcbacked.co/company/okomera. Accessed September 14, 2026.
VCBacked. (2024). Okomera — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/okomera
{{cite web |title=Okomera — Funding & Investors |url=https://www.vcbacked.co/company/okomera |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated